Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach

Tumor heterogeneity can contribute to the development of therapeutic resistance in cancer, including advanced breast cancers. The object of the Halifax project was to identify new treatments that would address mechanisms of therapeutic resistance through tumor heterogeneity by uncovering combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Lowe, Leroy, LaValley, J. William, Felsher, Dean W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771755/
https://www.ncbi.nlm.nih.gov/pubmed/36627896
http://dx.doi.org/10.20517/cdr.2022.40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771755/
https://www.ncbi.nlm.nih.gov/pubmed/36627896
http://dx.doi.org/10.20517/cdr.2022.40

Ejemplares similares